Article Text

Download PDFPDF
Colour versus grey-scale display of images on high-resolution spectral OCT
  1. M Brar1,
  2. D-U G Bartsch1,
  3. N Nigam1,
  4. F Mojana1,
  5. L Gomez1,2,
  6. L Cheng1,
  7. J Hedaya1,
  8. W R Freeman1
  1. 1
    Department of Ophthalmology, University of California, San Diego, Shiley Eye Center, La Jolla, California, USA
  2. 2
    Department of Ophthalmology, Institute of Ophthalmic Subspecialties (ISEO), Tijuana, Mexico
  1. Dr W R Freeman, University of California, San Diego Department of Ophthalmology, Shiley Eye Center, 0946, Joan and Irwin Jacobs Retina Center, 9415 Campus Point Drive, La Jolla, CA 92037, USA; freeman{at}eyecenter.ucsd.edu

Abstract

Aim: To determine whether colour or grey-scale images from high-resolution spectral optical coherence tomography (OCT) are superior in visualising clinically important details of retinal structures.

Methods: Patients with macular pathologies were imaged using spectral OCT (OTI, Toronto, Canada). Two reviewers independently analysed the retinal structures and pathologies and graded them on a four-point scale on the basis of the visibility. A third reviewer masked to the results then reviewed images where there was a different score for colour versus grey scale.

Results: Statistical analysis showed the grey-scale image to be significantly better in visualising the details of epiretinal membrane, photoreceptor and retinal pigment epithelium layer morphology than the colour scale image (p = 0.00088–0.0006). In 16.17% of eyes, the colour image led to the false impression of photoreceptor disruption.

Conclusion: Grey-scale images are qualitatively superior to the colour-scale images on high-resolution spectral OCT. Colour images can be misleading, as the displayed colours are false colours, and the observer may see a dramatic change in colour and interpret that as a large change in the OCT reflectivity.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Competing interests: None.

  • Funding: NIH grant EY007366, EY01623.

  • Ethics approval: Ethics approval was provided by University of California, San Diego.

  • Patient consent: Obtained.

Linked Articles

  • At a glance
    Harminder S Dua Arun D Singh